Late last week, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical Tetraphase Pharmaceuticals (NASDAQ: TTPH):
It’s been a stop-start effort since November’s low, but the turnaround effort from Tetraphase Pharmaceuticals has indeed taken hold. The former resistance line at $4.18 has now become a floor, and we’ve seen several....More>>>
Related ECH China And Copper ETFs: Not The Relationship You Think Investors Aren't Too Excited About Lithium Rally About The Latin America 40 ETF (Seeking Alpha)
If the current pace is maintained for the rest of this....More>>>
Stocks discussed on the in-depth session of Jim Cramer’s Mad Money TV Program, Monday, October 17.
Investors are running away. What is pushing them? A combination of upcoming election, the Fed’s looming rate hike and weak consumers are making investors wait on the sidelines.
“I am not making any kind of statement about the election in November. But I do think that....More>>>
I read the recent news of the big names who wrote $100 million checks to Theranos and wondered how they could have made such gigantic bad bets. Are there parallels to the Madoff scandal?
A veteran medical technology investor concludes that there may be two big reasons they agreed to invest in Theranos — it seemed to offer a compelling mission to the managers of their family offices....More>>>
Hows that New Year’s resolution to get back to the gym going? Yeah, thought so. But if you find the right facility, you have plenty of time to shape up in time for beach season.
See Also: Healthy Habits That Will Save You Money
Do a test workout. Take advantage of the free trial at a few gyms. Be sure to go when you typically work out, try the classes and use the locker room.....More>>>